Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B
Author(s) -
YaoChun Hsu,
ChunYing Wu,
H.-Y. Lane,
ChungYu Chang,
C.-M. Tai,
Cheng-Hao Tseng,
GinHo Lo,
DawShyong Perng,
J.-T. Lin,
LeinRay Mo
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku041
Subject(s) - hepatocellular carcinoma , medicine , chronic hepatitis , gastroenterology , cirrhosis , hepatitis b , virology , virus
We aimed to identify determinants of hepatocellular carcinoma (HCC) in cirrhotic patients who received nucleos(t)ide analogues for chronic hepatitis B (CHB).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom